ScoreComparison
Company
Score
Quality
Valuation
Financial
Technical
Why is CANbridge Pharmaceuticals Inc. ?
1
With a Negative Book Value, the company has a Weak Long Term Fundamental Strength
- Poor long term growth as Operating profit has grown by an annual rate 27.77% of over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -49.26
2
Flat results in Dec 24
- RAW MATERIAL COST(Y) Grown by 10.74% (YoY)
- CASH AND EQV(HY) Lowest at HKD 11.18 MM
- NET SALES(Q) Lowest at HKD 43.73 MM
3
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 1453.19%, its profits have risen by 1.8%
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is CANbridge Pharmaceuticals Inc. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
CANbridge Pharmaceuticals Inc.
1453.19%
3.07
177.06%
Hang Seng Hong Kong
27.36%
1.06
25.88%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-17.07%
EBIT Growth (5y)
27.77%
EBIT to Interest (avg)
-49.26
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.07
Sales to Capital Employed (avg)
9.42
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
-1.95
EV to EBIT
-2.32
EV to EBITDA
-2.37
EV to Capital Employed
-2.16
EV to Sales
69.69
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
Negative BV
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Mildly Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
No Trend
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend
Not enough Data to analyse Financial Trend
Not enough Data to analyse Financial Trend
Here's what is working for CANbridge Pharmaceuticals Inc.
Operating Profit
Highest at HKD -116.85 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (HKD MM)
Pre-Tax Profit
Highest at HKD -144.97 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (HKD MM)
Net Profit
Highest at HKD -144.97 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (HKD MM)
Here's what is not working for CANbridge Pharmaceuticals Inc.
Net Sales
Lowest at HKD 43.73 MM
in the last five periodsMOJO Watch
Near term sales trend is negative
Net Sales (HKD MM)
Net Sales
Fallen at -32.34%
Year on Year (YoY)MOJO Watch
Near term sales trend is negative
Net Sales (HKD MM)
Cash and Eqv
Lowest at HKD 11.18 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
Raw Material Cost
Grown by 10.74% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
